Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Squamous Cell × nilotinib × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 28 Leukemia 13 Gastrointestinal Stromal Tumors 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Leukemia, Myeloid, Chronic-Phase 6 Philadelphia Chromosome 3 Neoplasms 3 Leukemia, Myeloid 3 Hematologic Diseases 3 Bone Marrow Diseases 3 Myeloproliferative Disorders 2 Melanoma 2 Bronchiolitis Obliterans Syndrome 2 Blast Crisis 2 Synovitis, Pigmented Villonodular 1 Recurrence 1 Piebaldism 1 Neurofibromatoses 1 Neurofibroma, Plexiform 1 Neurofibroma 1 Neoplastic Processes 1 Neoplasms by Histologic Type 1 Neoplasm Metastasis 1 Mastocytosis, Systemic 1 Leukemia, Myeloid, Accelerated Phase 1 Hypereosinophilic Syndrome 1 Hematologic Neoplasms 1 Glioma 1 Giant Cell Tumor of Tendon Sheath 1 Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Cisplatin 24 Cetuximab 16 Radiotherapy 14 Carboplatin 13 pembrolizumab 11 Paclitaxel 9 Drug Therapy 8 Radiotherapy, Intensity-Modulated 6 Radiation 6 Fluorouracil 6 Erlotinib Hydrochloride 6 Nivolumab 5 Docetaxel 5 130-nm albumin-bound paclitaxel 5 Panitumumab 4 Chemoradiotherapy 3 Capecitabine 3 Bevacizumab 3 Albumin-Bound Paclitaxel 3 Afatinib 3 selinexor 2 figitumumab 2 Restraint, Physical 2 Radiosurgery 2 Methotrexate 2 Lapatinib 2 Everolimus 2 Esophagectomy 2 Cyclophosphamide 2 zalutumumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡